Use of a Single, Independent IRB: Case Study of an NIH Funded Consortium
- PMID: 29546249
- PMCID: PMC5846487
- DOI: 10.1016/j.conctc.2017.09.001
Use of a Single, Independent IRB: Case Study of an NIH Funded Consortium
Abstract
In 2014, the Request for Applications from the National Institutes of Health (NIH) for continued funding of a multi-site clinical and mechanistic research network, Inner City Asthma Consortium (ICAC), called for "efficient IRB review and approval for multi-center studies" and "IRB approval within 30 days from submission". These requirements were precursors to the NIH policy of single IRB review for multi-site studies. Here we share our challenges, implementation processes, results, and recommendations, using a single, independent IRB.
Keywords: Consortium; Independent IRB; Multi-site studies; NIH Policy; Single IRB.
References
-
- Final NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research, NOT-OD-16-094, https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-094.html.
-
- 45 CFR 46.103(b)(5), and Terms of the Federal Wide Assurance for the Protection of Human Subjects (June 17, 2011) http://www.hhs.gov/ohrp/assurances/assurances/filasurt.html.
-
- http://www.icaccirb.orghttp://www.icaccirb.org(July 2015).
-
- Guidance for Industry: Using a Centralized IRB Review Process in Multicenter Clinical Trials (March 2006). http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM127013.pdf.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources